Publications

Found 356 results
Filters: First Letter Of Last Name is S  [Clear All Filters]
2022
Ruiz DFZegarra, Kim DV, Norwood K, Saldana-Morales FB, Kim M, Ng C, Callaghan R, Uddin M, Chang L-C, Longman RS et al..  2022.  Microbiota manipulation to increase macrophage IL-10 improves colitis and limits colitis-associated colorectal cancer.. Gut Microbes. 14(1):2119054.
Jarick KJ, Topczewska PM, Jakob MO, Yano H, Arifuzzaman M, Gao X, Boulekou S, Stokic-Trtica V, Leclère PS, Preußer A et al..  2022.  Non-redundant functions of group 2 innate lymphoid cells.. Nature. 611(7937):794-800.
Jarick KJ, Topczewska PM, Jakob MO, Yano H, Arifuzzaman M, Gao X, Boulekou S, Stokic-Trtica V, Leclère PS, Preußer A et al..  2022.  Non-redundant functions of group 2 innate lymphoid cells.. Nature. 611(7937):794-800.
Jarick KJ, Topczewska PM, Jakob MO, Yano H, Arifuzzaman M, Gao X, Boulekou S, Stokic-Trtica V, Leclère PS, Preußer A et al..  2022.  Non-redundant functions of group 2 innate lymphoid cells.. Nature. 611(7937):794-800.
Chen K, Chen J, Smith E, Mathani P, Longman R, Lukin D, Scherl E, Gerber J, Battat R.  2022.  Serum Ustekinumab Concentrations Are Associated With Improved Outcomes With the Magnetic Resonance Index of Activity for Crohn's Disease.. Inflamm Bowel Dis.
Chen K, Chen J, Smith E, Mathani P, Longman R, Lukin D, Scherl E, Gerber J, Battat R.  2022.  Serum Ustekinumab Concentrations Are Associated With Improved Outcomes With the Magnetic Resonance Index of Activity for Crohn's Disease.. Inflamm Bowel Dis.
Mantel I, Sadiq BA, J Blander M.  2022.  Spotlight on TAP and its vital role in antigen presentation and cross-presentation.. Mol Immunol. 142:105-119.
Pan Y, Ahmed W, Mahtani P, Wong R, Longman R, Lukin DJeremy, Scherl EJ, Battat R.  2022.  Utility of Therapeutic Drug Monitoring for Tumor Necrosis Factor Antagonists and Ustekinumab in Postoperative Crohn's Disease.. Inflamm Bowel Dis. 28(12):1865-1871.
Zhou W, Zhou L, Zhou J, Chu C, Zhang C, Sockolow RE, Eberl G, Sonnenberg GF.  2022.  ZBTB46 defines and regulates ILC3s that protect the intestine.. Nature. 609(7925):159-165.
Zhou W, Zhou L, Zhou J, Chu C, Zhang C, Sockolow RE, Eberl G, Sonnenberg GF.  2022.  ZBTB46 defines and regulates ILC3s that protect the intestine.. Nature. 609(7925):159-165.
2021
Viladomiu M, Metz ML, Lima SF, Jin W-B, Chou L, Guo C-J, Diehl GE, Simpson KW, Scherl EJ, Longman RS.  2021.  Adherent-invasive E. coli metabolism of propanediol in Crohn's disease regulates phagocytes to drive intestinal inflammation.. Cell Host Microbe.
Viladomiu M, Metz ML, Lima SF, Jin W-B, Chou L, Guo C-J, Diehl GE, Simpson KW, Scherl EJ, Longman RS.  2021.  Adherent-invasive E. coli metabolism of propanediol in Crohn's disease regulates phagocytes to drive intestinal inflammation.. Cell Host Microbe.
Grigg JB, Shanmugavadivu A, Regen T, Parkhurst CN, Ahmed A, Joseph AM, Mazzucco M, Gronke K, Diefenbach A, Eberl G et al..  2021.  Antigen-presenting innate lymphoid cells orchestrate neuroinflammation.. Nature.
Grigg JB, Shanmugavadivu A, Regen T, Parkhurst CN, Ahmed A, Joseph AM, Mazzucco M, Gronke K, Diefenbach A, Eberl G et al..  2021.  Antigen-presenting innate lymphoid cells orchestrate neuroinflammation.. Nature.
Goc J, Lv M, Bessman NJ, Flamar A-L, Sahota S, Suzuki H, Teng F, Putzel GG, Eberl G, Withers DR et al..  2021.  Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer.. Cell. 184(19):5015-5030.e16.
Goc J, Lv M, Bessman NJ, Flamar A-L, Sahota S, Suzuki H, Teng F, Putzel GG, Eberl G, Withers DR et al..  2021.  Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer.. Cell. 184(19):5015-5030.e16.
Goc J, Lv M, Bessman NJ, Flamar A-L, Sahota S, Suzuki H, Teng F, Putzel GG, Eberl G, Withers DR et al..  2021.  Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer.. Cell. 184(19):5015-5030.e16.
Goc J, Lv M, Bessman NJ, Flamar A-L, Sahota S, Suzuki H, Teng F, Putzel GG, Eberl G, Withers DR et al..  2021.  Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer.. Cell. 184(19):5015-5030.e16.
Doron I, Leonardi I, Li XV, Fiers WD, Semon A, Bialt-DeCelie M, Migaud M, Gao IH, Lin W-Y, Kusakabe T et al..  2021.  Human gut mycobiota tune immunity via CARD9-dependent induction of anti-fungal IgG antibodies.. Cell.
Doron I, Mesko M, Li XV, Kusakabe T, Leonardi I, Shaw DG, Fiers WD, Lin W-Y, Bialt-DeCelie M, Román E et al..  2021.  Mycobiota-induced IgA antibodies regulate fungal commensalism in the gut and are dysregulated in Crohn's disease.. Nat Microbiol. 6(12):1493-1504.
Barbet G, Nair-Gupta P, Schotsaert M, Yeung ST, Moretti J, Seyffer F, Metreveli G, Gardner T, Choi A, Tortorella D et al..  2021.  TAP dysfunction in dendritic cells enables noncanonical cross-presentation for T cell priming.. Nat Immunol. 22(4):497-509.
Barbet G, Nair-Gupta P, Schotsaert M, Yeung ST, Moretti J, Seyffer F, Metreveli G, Gardner T, Choi A, Tortorella D et al..  2021.  TAP dysfunction in dendritic cells enables noncanonical cross-presentation for T cell priming.. Nat Immunol. 22(4):497-509.
Lima S, Gogokhia L, Viladomiu M, Chou L, Putzel G, Jin W, Pires S, Guo C-J, Gerardin Y, Crawford CV et al..  2021.  Transferable IgA-coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation.. Gastroenterology.
Malik F, Scherl E, Weber U, Carrino JA, Epsten M, Wichuk S, Pedersen SJ, Paschke J, Schwartzman S, Kroeber G et al..  2021.  Utility of magnetic resonance imaging in Crohn's associated sacroiliitis: A cross-sectional study.. Int J Rheum Dis.
Malik F, Scherl E, Weber U, Carrino JA, Epsten M, Wichuk S, Pedersen SJ, Paschke J, Schwartzman S, Kroeber G et al..  2021.  Utility of magnetic resonance imaging in Crohn's associated sacroiliitis: A cross-sectional study.. Int J Rheum Dis.